AGAPE ATP CORPORATION Income (Loss) from Equity Method Investments
AGAPE ATP CORPORATION (ATPC) reported Income (Loss) from Equity Method Investments of -$26.09 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-03-31
- AGAPE ATP CORPORATION income (loss) from equity method investments for the quarter ending 2019-12-31 was $0.00.
- AGAPE ATP CORPORATION income (loss) from equity method investments for the quarter ending 2019-09-30 was $0.00.
- AGAPE ATP CORPORATION income (loss) from equity method investments for the quarter ending 2019-06-30 was $0.00.
- AGAPE ATP CORPORATION income (loss) from equity method investments for the quarter ending 2019-03-31 was -$26.09K, a 724.04% decline year-over-year.
- AGAPE ATP CORPORATION income (loss) from equity method investments for fiscal 2019 was -$26.09K.
- AGAPE ATP CORPORATION income (loss) from equity method investments for fiscal 2019 was -$124.22K.
- AGAPE ATP CORPORATION income (loss) from equity method investments for fiscal 2018 was -$30.16K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | -$26.09K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | -$26.09K 10-Q · filed 2020-11-16 | -$72.12K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$26.09K 10-Q · filed 2020-08-13 | -$72.12K derived: sum of 3 quarters · filed 2020-08-13 | -$124.22K 10-K/A · filed 2019-12-02 |
| 2019-03-31 | -$26.09K 10-Q · filed 2020-05-14 | -$72.12K derived: sum of 2 quarters · filed 2020-05-14 | -$124.22K 10-Q · filed 2019-05-13 | -$158.56K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$46.03K 10-Q · filed 2019-02-15 | -$98.14K 10-Q · filed 2019-02-15 | -$132.47K derived: sum of 3 quarters · filed 2019-12-02 | -$128.29K derived: sum of 4 quarters · filed 2019-12-02 |
| 2018-09-30 | -$52.11K 10-Q · filed 2019-11-12 | -$86.44K derived: sum of 2 quarters · filed 2019-12-02 | -$82.26K derived: sum of 3 quarters · filed 2019-12-02 | |
| 2018-06-30 | -$34.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-02 | -$30.16K derived: sum of 2 quarters · filed 2019-12-02 | -$30.16K 10-K/A · filed 2019-12-02 | |
| 2018-03-31 | $4.18K 10-Q · filed 2019-05-13 | $4.18K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |